Clinical trial • Phase I • Oncology
Clinical trial in Advanced or metastatic solid tumors
Phase I trial for Advanced or metastatic solid tumors. 132 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced or metastatic solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 11-11-2025
- First CTIS Authorization Date
- 17-03-2026
Trial design
Phase I trial across 7 sites in France, Ireland, Spain.
- Target Sample Size
- 132
Recruitment
- Planned Sample Size
- 132
- Recruitment Window Months
- 30
Geography
- Total Number Of Sites
- 7
- Total Number Of Participants
- 48
France
- Earliest CTIS Part Ii Submission Date
- 11-03-2026
- Latest Decision Or Authorization Date
- 18-03-2026
- Processing Time Days
- 7
- Number Of Sites
- 3
- Number Of Participants
- 30
Sites
- Site Name
- Institut Gustave Roussy
- Department Name
- Innovation thérapeutique et essais cliniques précoces
- Principal Investigator Name
- Joana MOURATO RIBEIRO
- Principal Investigator Email
- joana-mourato.ribeiro@gustaveroussy.fr
- Contact Person Name
- Joana MOURATO RIBEIRO
- Contact Person Email
- joana-mourato.ribeiro@gustaveroussy.fr
- Site Name
- Fondation Hopital Saint Joseph
- Department Name
- Oncologie
- Principal Investigator Name
- Marine SLIM
- Principal Investigator Email
- mslim@ghpsj.fr
- Contact Person Name
- Marine SLIM
- Contact Person Email
- mslim@ghpsj.fr
- Site Name
- Institut De Cancerologie De L Ouest
- Department Name
- Oncologie Médicale
- Principal Investigator Name
- Mario CAMPONE
- Principal Investigator Email
- mario.campone@ico.unicancer.fr
- Contact Person Name
- Mario CAMPONE
- Contact Person Email
- mario.campone@ico.unicancer.fr
Ireland
- Earliest CTIS Part Ii Submission Date
- 24-02-2026
- Latest Decision Or Authorization Date
- 20-03-2026
- Processing Time Days
- 24
- Number Of Sites
- 1
- Number Of Participants
- 6
Sites
- Site Name
- Mater Misericordiae University Hospital
- Department Name
- Oncology
- Principal Investigator Name
- Austin Duffy
- Principal Investigator Email
- austin.duffy@startdublin.com
- Contact Person Name
- Austin Duffy
- Contact Person Email
- austin.duffy@startdublin.com
Spain
- Earliest CTIS Part Ii Submission Date
- 02-03-2026
- Latest Decision Or Authorization Date
- 17-03-2026
- Processing Time Days
- 15
- Number Of Sites
- 3
- Number Of Participants
- 12
Sites
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Oncology
- Principal Investigator Name
- Juan José Soto Castillo
- Principal Investigator Email
- juanj.soto@startmadrid.com
- Contact Person Name
- Juan José Soto Castillo
- Contact Person Email
- juanj.soto@startmadrid.com
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Principal Investigator Name
- Bernard Doger de Speville
- Principal Investigator Email
- bernard.doger@startmadrid.com
- Contact Person Name
- Bernard Doger de Speville
- Contact Person Email
- bernard.doger@startmadrid.com
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- Oncology
- Principal Investigator Name
- Tatiana Hernandez Guerrero
- Principal Investigator Email
- Tatiana.hernandez@start-barcelona.com
- Contact Person Name
- Tatiana Hernandez Guerrero
- Contact Person Email
- Tatiana.hernandez@start-barcelona.com
Sponsor
Primary sponsor
- Full Name
- Olema Pharmaceuticals Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Related trials
Other published trials that may interest you.